Works matching DE "PIOGLITAZONE"

Results: 978

Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.

Published in:

Journal of Parkinson's Disease, 2015, v. 5, n. 4, p. 731, doi. 10.3233/JPD-150666

By:

Simon, David K.;
Simuni, Tanya;
Elm, Jordan;
Clark-Matott, Joanne;
Graebner, Allison K.;
Baker, Liana;
Dunlop, Susan R.;
Emborg, Marina;
Kamp, Cornelia;
Morgan, John C.;
Ross, G. Webster;
Sharma, Saloni;
Ravina, Bernard

Publication type:

Article

A systematic approach to evaluating instrumental variable assumptions: applied example of glucose-lowering medications and risk for hospitalized heart failure in older adults.

Published in:

American Journal of Epidemiology, 2025, v. 194, n. 6, p. 1544, doi. 10.1093/aje/kwae329

By:

Htoo, Phyo T;
Edwards, Jessie K;
Gokhale, Mugdha;
Pate, Virginia;
Buse, John B;
Jonsson-Funk, Michele;
Stürmer, Til

Publication type:

Article

Drug Repositioning of Pioglitazone in Management and Improving the Cognitive Function among the Patients With Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Published in:

Neurology India, 2023, v. 71, n. 6, p. 1132, doi. 10.4103/0028-3886.391397

By:

Basutkar, Roopa;
Sudarsan, Pooja;
Robin, Sandra;
Bhaskar, Vahini;
Viswanathan, Balasubramaniam;
Sivasankaran, Ponnusankar

Publication type:

Article

Competition of zinc ion for the [2Fe-2S] cluster binding site in the diabetes drug target protein mitoNEET.

Published in:

BioMetals, 2012, v. 25, n. 6, p. 1177, doi. 10.1007/s10534-012-9580-4

By:

Tan, Guoqiang;
Landry, Aaron;
Dai, Ruili;
Wang, Li;
Lu, Jianxin;
Ding, Huangen

Publication type:

Article

Response to Letter. "Romosozumab and cardiovascular safety- should we learn lessons from Pioglitazone?.".

Published in:

2022

By:

Tominaga, Ayako;
Wada, Keiji;
Okazaki, Ken;
Nishi, Hideharu;
Terayama, Yasushi;
Kato, Yoshiharu

Publication type:

Letter to the Editor

Effect of dipeptidyl peptidase IV inhibitors, thiazolidinedione, and sulfonylurea on osteoporosis in patients with type 2 diabetes: population-based cohort study.

Published in:

Osteoporosis International, 2021, v. 32, n. 9, p. 1705, doi. 10.1007/s00198-020-05801-6

By:

Yang, B. R.;
Cha, S. H.;
Lee, K. E.;
Kim, J. W.;
Lee, J.;
Shin, K.-H.

Publication type:

Article

Impact of pioglitazone on bone mineral density and bone marrow fat content.

Published in:

Osteoporosis International, 2017, v. 28, n. 11, p. 3261, doi. 10.1007/s00198-017-4164-3

By:

Pop, L.;
Lingvay, I.;
Yuan, Q.;
Li, X.;
Adams-Huet, B.;
Maalouf, N.

Publication type:

Article

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 1, p. 127, doi. 10.1007/s00228-023-03586-1

By:

Zachou, Maria;
Flevari, Pagona;
Nasiri-Ansari, Narjes;
Varytimiadis, Constantinos;
Kalaitzakis, Evangelos;
Kassi, Eva;
Androutsakos, Theodoros

Publication type:

Article

Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 12, p. 1655, doi. 10.1007/s00228-017-2326-z

By:

Pariente, Antoine;
Mansiaux, Yohann;
Jarné, Ana;
Salvo, Francesco;
Pageot, Cécile;
Bezin, Julien;
Smith, Andy;
Bégaud, Bernard

Publication type:

Article

Thiazolidinediones improve flow-mediated dilation: a meta-analysis of randomized clinical trials.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 4, p. 385, doi. 10.1007/s00228-015-1999-4

By:

Stojanović, Marko;
Prostran, Milica;
Radenković, Miroslav

Publication type:

Article

Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 1, p. 37, doi. 10.1007/s00228-013-1592-7

By:

Haberer, Lynda;
McSherry, Iain;
Cargill, Anna;
McCarthy, Linda

Publication type:

Article

Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!

Published in:

2012

By:

Hillaire-Buys, Dominique;
Faillie, Jean-Luc;
Montastruc, Jean-Louis;
Petit, Pierre

Publication type:

Letter

Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products.

Published in:

Basic Research in Cardiology, 2012, v. 107, n. 6, p. 1, doi. 10.1007/s00395-012-0306-0

By:

Li, Fei;
Cai, Zhejun;
Chen, Fang;
Shi, Xucong;
Zhang, Qiao;
Chen, Si;
Shi, Jiawei;
Wang, Dao;
Dong, Nianguo

Publication type:

Article

Pioglitazone Ameliorates Endothelial Dysfunction in Those with Impaired Glucose Regulation among the First-Degree Relatives of Type 2 Diabetes Mellitus Patients.

Published in:

Medical Principles & Practice, 2013, v. 22, n. 2, p. 156, doi. 10.1159/000341770

By:

Yu, Xuemei;
Chen, Peihong;
Wang, Hongtao;
Zhu, Tong

Publication type:

Article

Computational Evaluation on Molecular Structure, Charge, NMR, Electronic (HOMO-LUMO) Properties, and Spectroscopic Profiling of Pioglitazone with Molecular Docking Studies.

Published in:

Trends in Sciences, 2022, v. 19, n. 24, p. 1, doi. 10.48048/tis.2022.2872

By:

Segar, Soundhariya;
Ravikumar, Keerthana;
Jayasheela;
Sengeny, Periandy

Publication type:

Article

Luteolin alleviates inflammation and autophagy of hippocampus induced by cerebral ischemia/reperfusion by activating PPAR gamma in rats.

Published in:

BMC Complementary Medicine & Therapies, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12906-022-03652-8

By:

Li, Lu;
Pan, Guanghua;
Fan, Rong;
Li, Dalei;
Guo, Lei;
Ma, Lili;
Liang, Hui;
Qiu, Jiaoxue

Publication type:

Article

Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT.

Published in:

International Journal of Reproductive Biomedicine, 2016, v. 14, n. 12, p. 743

By:

Sohrevardi, Seyed Mojtaba;
Nosouhi, Fahime;
Khalilzade, Saeed Hossein;
Kafaie, Parichehr;
Karimi-Zarchi, Mojgan;
Halvaei, Iman;
Mohsenzadeh, Mehdi

Publication type:

Article

Analytical quality by design-based RP-HPLC method for quantification of pioglitazone and candesartan cilexetil in bilayer tablet and its forced degradation studies.

Published in:

Pharmacia (0428-0296), 2023, v. 70, n. 1, p. 27, doi. 10.3897/pharmacia.70.e95099

By:

Kola, Hephzibah;
Shanmugasundaram, Sangeetha

Publication type:

Article

The Influence of Oral Antidiabetic Drugs on Cellular Drug Uptake Mediated by Hepatic OATP Family Members.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2013, v. 112, n. 4, p. 244, doi. 10.1111/bcpt.12031

By:

Klatt, Sabine;
Fromm, Martin F.;
König, Jörg

Publication type:

Article

Pioglitazone Eases Testicular Torsion/Detorsion-Induced Ischemia-Reperfusion Injury in Rats.

Published in:

Journal of Urological Surgery, 2023, v. 10, n. 2, p. 167, doi. 10.4274/jus.galenos.2022.2022.0047

By:

Şentürk, İrfan Yıldırım;
Değer, Müslim Doğan;
Aydın, Muhammed Ali;
Madendere, Serdar;
Kaya, Oktay;
Taştekin, Ebru;
Aktoz, Tevfik

Publication type:

Article

DEVELOPMENT AND VALIDATION OF A NOVEL RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ALOGLIPTIN BENZOATE AND PIOGLITAZONE HCL IN PHARMACEUTICAL DOSAGE FORM.

Published in:

International Journal of Chemical & Pharmaceutical Analysis, 2017, v. 4, n. 3, p. 1, doi. 10.21276/ijcpa

By:

Potdar, Ketaki Sharad;
Kalshetti, Mallinath Shankareppa;
Patil, Ravikant Yashwantrao

Publication type:

Article

Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes.

Published in:

Annals of Clinical & Translational Neurology, 2015, v. 2, n. 12, p. 1071, doi. 10.1002/acn3.260

By:

Natrajan, Muktha S.;
Komori, Mika;
Kosa, Peter;
Johnson, Kory R.;
Wu, Tianxia;
Franklin, Robin J. M.;
Bielekova, Bibiana

Publication type:

Article

Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.

Published in:

Dementia & Geriatric Cognitive Disorders, 2020, v. 49, n. 5, p. 423, doi. 10.1159/000510677

By:

Muñoz-Jiménez, Mario;
Zaarkti, Alí;
García-Arnés, Juan Antonio;
García-Casares, Natalia

Publication type:

Article

Managing Comorbidities in Patients with Chronic Heart Failure: First, Do No Harm.

Published in:

American Journal of Cardiovascular Drugs, 2015, v. 15, n. 3, p. 171, doi. 10.1007/s40256-015-0115-6

By:

DeJongh, Beth;
Birkeland, Kade;
Brenner, Michael

Publication type:

Article

Pioglitazone is a Valid Alternative to Rosiglitazone.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 6, p. 357, doi. 10.2165/11595990-000000000-00000

By:

Derosa, Giuseppe

Publication type:

Article

Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 2, p. 115, doi. 10.2165/11587580-000000000-00000

By:

Hernandez, Adrian V.;
Usmani, Ali;
Rajamanickam, Anitha;
Moheet, A.

Publication type:

Article

Pioglitazone, a peroxisome proliferator‑activated receptor γ agonist, induces cell death and inhibits the proliferation of hypoxic HepG2 cells by promoting excessive production of reactive oxygen species.

Published in:

Oncology Letters, 2024, v. 27, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14294

By:

Huang, Guohao;
Zhang, Mengfan;
Wang, Manzhou;
Xu, Wenze;
Duan, Xuhua;
Han, Xinwei;
Ren, Jianzhuang

Publication type:

Article

Pioglitazone mediates apoptosis in Caki cells via downregulating c-FLIP(L) expression and reducing Bcl-2 protein stability.

Published in:

Oncology Letters, 2021, v. 22, n. 4, p. N.PAG, doi. 10.3892/ol.2021.13004

By:

Jang, Ji Hoon;
Lee, Tae-Jin;
Sung, Eon-Gi;
Song, In-Hwan;
Kim, Joo-Young

Publication type:

Article

Ligands of the peroxisome proliferator-activated receptor γ inhibit hepatoce llular carcinoma cell proliferation.

Published in:

Oncology Letters, 2017, v. 14, n. 4, p. 4767, doi. 10.3892/ol.2017.6731

By:

ZHE JIN;
BAOXING JIA;
YU FU;
LUDONG TAN;
QINGMIN CHEN;
PEIQIANG JIANG;
YAHUI LIU

Publication type:

Article

Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study.

Published in:

Oncology Letters, 2016, v. 12, n. 1, p. 89, doi. 10.3892/ol.2016.4566

By:

YOUHONG DONG;
ANPING WANG

Publication type:

Article

Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells.

Published in:

Oncology Letters, 2014, v. 8, n. 6, p. 2709, doi. 10.3892/ol.2014.2553

By:

ITASU NINOMIYA;
KEISUKE YAMAZAKI;
KATSUNOBU OYAMA;
HIRONORI HAYASHI;
HIDEHIRO TAJIMA;
HIROHISA KITAGAWA;
SACHIO FUSHIDA;
TAKASHI FUJIMURA;
TETSUO OHTA

Publication type:

Article

Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study.

Published in:

Molecular & Clinical Oncology, 2015, v. 3, n. 1, p. 115, doi. 10.3892/mco.2014.435

By:

SHUJI SUMIE;
TAKUMI KAWAGUCHI;
ATSUSHI KAWAGUCHI;
RYOKO KUROMATSU;
MASAHITO NAKANO;
MANABU SATANI;
SHINGO YAMADA;
SHUSUKE OKAMURA;
YUKO YONEZAWA;
TATSUYUKI KAKUMA;
TAKUJI TORIMURA;
MICHIO SATA

Publication type:

Article

Effect of Pioglitazone on endoplasmic reticulum stress regarding in situ perfusion rat model.

Published in:

Clinical Hemorheology & Microcirculation, 2021, v. 79, n. 2, p. 311, doi. 10.3233/CH-211163

By:

Telek, Vivien;
Erlitz, Luca;
Caleb, Ibitamuno;
Nagy, Tibor;
Vecsernyés, Mónika;
Balogh, Bálint;
Sétáló Jr., György;
Hardi, Péter;
Jancsó, Gábor;
Takács, Ildikó

Publication type:

Article

Banting memorial lecture 2022: 'Type 2 diabetes and nonalcoholic fatty liver disease: Partners in crime'.

Published in:: Diabetic Medicine, 2022, v. 39, n. 10, p. 1, doi. 10.1111/dme.14912
Publication type:: Article

Pioglitazone and bladder cancer: improving research methods.

Published in:

2020

By:

Ripamonti, E.;
Azoulay, L.;
Abrahamowicz, M.;
Platt, R. W.;
Suissa, S.

Publication type:

Letter to the Editor

More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.

Published in:

Diabetic Medicine, 2020, v. 37, n. 2, p. 194, doi. 10.1111/dme.14179

By:

Dankner, R.;
Roth, J.

Publication type:

Article

Pioglitazone: inexpensive; very effective at reducing HbA1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit.

Published in:

Diabetic Medicine, 2019, v. 36, n. 9, p. 1185, doi. 10.1111/dme.14053

By:

Ryder, Robert E. J.;
DeFronzo, Ralph A.

Publication type:

Article

A systematic review of observational studies of the association between pioglitazone use and bladder cancer.

Published in:

Diabetic Medicine, 2019, v. 36, n. 1, p. 22, doi. 10.1111/dme.13854

By:

Ripamonti, E.;
Azoulay, L.;
Abrahamowicz, M.;
Platt, R.W.;
Suissa, S.

Publication type:

Article

Combination therapy with multiple oral hypoglycaemic agents together with short-term basal insulin in new-onset Type 2 diabetes mellitus with marked hyperglycaemia.

Published in:

Diabetic Medicine, 2017, v. 34, n. 9, p. 1322, doi. 10.1111/dme.13393

By:

Ray, S.;
Mukherjee, J. J.

Publication type:

Article

Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 180, doi. 10.1111/dme.13125

By:

Kumar, S.;
Jang, H. C.;
Demirağ, N. G.;
Skjøth, T. V.;
Endahl, L.;
Bode, B.

Publication type:

Article

Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.

Published in:

Diabetic Medicine, 2016, v. 33, n. 9, p. e17, doi. 10.1111/dme.12988

By:

Oei, E.;
Samad, N.;
Visser, A.;
Chowdhury, T. A.;
Fan, S. L.

Publication type:

Article

Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes.

Published in:

Diabetic Medicine, 2016, v. 33, n. 7, p. 926, doi. 10.1111/dme.13041

By:

Durán‐Garcia, S.;
Lee, J.;
Yki‐Järvinen, H.;
Rosenstock, J.;
Hehnke, U.;
Thiemann, S.;
Patel, S.;
Woerle, H.‐J.

Publication type:

Article

NICE guidelines for Type 2 diabetes: revised but still not fit for purpose.

Published in:

Diabetic Medicine, 2015, v. 32, n. 11, p. 1398, doi. 10.1111/dme.12952

By:

O'Hare, J. P.;
Hanif, W.;
Millar‐Jones, D.;
Bain, S.;
Hicks, D.;
Leslie, R. D.;
Barnett, A. H.

Publication type:

Article

Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoter.

Published in:

Diabetic Medicine, 2015, v. 32, n. 4, p. 438, doi. 10.1111/dme.12703

By:

Ryder, R. E. J.

Publication type:

Article

Pioglitazone: reports of its death are greatly exaggerated.

Published in:

Diabetic Medicine, 2015, v. 32, n. 4, p. e9, doi. 10.1111/dme.12736

By:

Ryder, R. E. J.

Publication type:

Article

Pioglitazone: are rumours of its death exaggerated?

Published in:

Diabetic Medicine, 2015, v. 32, n. 4, p. 431, doi. 10.1111/dme.12708

By:

Gale, E. A. M.

Publication type:

Article

Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit.

Published in:

Diabetic Medicine, 2015, v. 32, n. 3, p. 305, doi. 10.1111/dme.12627

By:

Ryder, R. E. J.

Publication type:

Article

Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone.

Published in:

Clinical Kidney Journal, 2021, v. 14, n. 7, p. 1715, doi. 10.1093/ckj/sfab062

By:

Mao, Zhiguo;
Valluru, Manoj K;
Ong, Albert C M

Publication type:

Article

A randomized phase 1b cross-over study of the safety of low-dose pioglitazone for treatment of autosomal dominant polycystic kidney disease.

Published in:

Clinical Kidney Journal, 2021, v. 14, n. 7, p. 1738, doi. 10.1093/ckj/sfaa232

By:

Blazer-Yost, Bonnie L;
Bacallao, Robert L;
Erickson, Bradley J;
LaPradd, Michelle L;
Edwards, Marie E;
Sheth, Nehal;
Swinney, Kim;
Ponsler-Sipes, Kristen M;
Moorthi, Ranjani N;
Perkins, Susan M;
Torres, Vicente E;
Moe, Sharon M

Publication type:

Article

Molecular level investigation of curcumin self-assembly induced by trigonelline and nanoparticle formation.

Published in:

Applied Nanoscience, 2020, v. 10, n. 11, p. 3987, doi. 10.1007/s13204-020-01526-4

By:

Sharma, Sweta;
Awad, Ibrahim E.;
Yadav, Arpita;
Poirier, Raymond A.

Publication type:

Article